„First Line“
Suchergebnisse
3.416 Treffer
-
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study
-
Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan
-
Drug-eluting Microspheres Compared to Conventional Transarterial Chemoembolization as First Line Treatment for Unresectable Hepatocellular Carcinoma: A Single-center Retrospective Cost-utility Analysis
-
Decomposition of Fourth-Order Linear Time-Varying Systems into its Third- and First-Order Commutative Pairs
-
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro
-
Symptom and quality of life improvement in LUX-Lung 8, an open-label phase III study of second-line Afatinib versus Erlotinib in patients with advanced squamous cell carcinoma of the lung after first-line platinum-based chemotherapy
-
Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury
-
Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
-
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
-
A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry
-
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
-
Theories to support method development in comprehensive two‐dimensional liquid chromatography – A review
-
Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)
-
Spin arrangements of the first family line groups
-
Kopf-Hals-Tumoren: PD-1-Inhibition als neuer First-Line-Standard
-
First-line therapy for elderly patients with advanced renal cell carcinoma in the immuno-oncology era: a network meta-analysis
-
ON GENERALIZED SOLUTIONS OF LINEAR DIFFERENTIAL EQUATIONS OF THE FIRST ORDER
-
Decomposition of Second-Order Discrete-Time Linear Time-Varying Systems into First-Order Commutative Pairs
-
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
-
Considerations for Choosing First-Line Urate-Lowering Treatment in Older Patients with Comorbid Conditions